Pituitary disease and pregnancy.

Area of Science:

• Endocrinology
• Obstetrics
• Reproductive Medicine

Background:

• Pregnancy significantly alters pituitary gland size and function, complicating disease management.
• Pituitary adenomas pose risks to maternal and fetal health, with limited drug safety data during gestation.
• Pituitary adenoma growth during pregnancy is a concern, necessitating careful monitoring.

Purpose of the Study:

• To review diagnostic challenges of pituitary adenomas in pregnant women.
• To provide evidence-based treatment recommendations for pituitary adenomas during pregnancy.
• To discuss management of hormone replacement and differential diagnoses in pregnant patients.

Main Methods:

• Literature review focusing on pituitary adenomas (prolactin, growth hormone, ACTH-secreting) in pregnancy.
• Examination of diagnostic strategies and treatment algorithms for pregnant patients.
• Analysis of hormone replacement therapy optimization and differential diagnosis of postpartum pituitary disorders.

Main Results:

• Diagnostic difficulties arise from physiological pituitary changes during pregnancy.
• Evidence-based recommendations for managing prolactinomas, growth hormone-secreting, and ACTH-secreting adenomas are presented.
• Optimized hormone replacement and differential diagnosis of Sheehan's syndrome versus lymphocytic hypophysitis are discussed.

Conclusions:

• Effective management of pituitary adenomas in pregnancy requires tailored diagnostic and therapeutic approaches.
• Careful monitoring and evidence-based interventions are crucial for maternal and fetal well-being.
• Understanding differential diagnoses is vital for appropriate postpartum pituitary disorder management.